https://practicaldermatology.com/news/with-label-extension-simponi-aria-approved-for-psa-in-kids-as-young-as-two/2460549/
With Label Extension, Simponi Aria Approved for PsA in Kids as Young as Two - PracticalDermatology
The FDA has approved Simponi Aria (golimumab) for the treatment of active pJIA for patients two years of age and older and has extended the PsA indic…
simponi ariayoung twolabelextensionapproved